FORMULA FOUR - WAF
FORMULA FOUR - WAF
Discontinued
DIN Number
02193965
Drug Class
Human
Market Date
Dec 31, 1996
Company
HC
hillestad pharmaceuticals usa
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02193965
AIG Number0428177001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A09AA02 MULTIENZYMES (LIPASE, PROTEASE ETC)
Product Specifications
Dosage FormWafer
Route of AdministrationOral
AHFS Classification44:00.00
Health Canada Classification
ACTIVE INGREDIENTS (4)
ASPERGILLUS NIGERActive
Strength: 35 MG / WAF
Monograph: ASPERGILLUS NIGER
ASPERGILLUS ORYZAEActive
Strength: 30 MG / WAF
Monograph: ASPERGILLUS ORYZAE
PAPAYAActive
Strength: 115 MG / WAF
Monograph: PAPAYA
PINEAPPLEActive
Strength: 25 MG / WAF
Monograph: PINEAPPLE